Expert review of molecular diagnosticsHumansEstrogen Receptor alphaBreast NeoplasmsCirculating Tumor DNAFemale
ESR1 ctDNA testing: literature review and comparison of assays for ESR1 mutation detection in advanced hormone receptor-positive breast cancer.
Alexander Yarunin, Hanna Ahlgren, Moumita Chaki, Christopher Morrow, Xiaodun Li, John Longshore
Published: 202510.1080/14737159.2025.2576021
Abstract
INTRODUCTION: Aromatase inhibitors (AI) plus CDK4/6 inhibitors are the current first-line standard-of-care for hormone receptor (HR)-positive/HER2-negative advanced breast cancer (ABC). However, mutations in ESR1 (ESR1m), the gene encoding the estrog…
Preview only. Read the full abstract at the source